| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.43▲ | 1.38▲ | 1.38▲ | 1.38▲ | 1.43▲ |
| MA10 | 1.38▲ | 1.35▲ | 1.35▲ | 1.44▲ | 0.87▲ |
| MA20 | 1.37▲ | 1.38▲ | 1.39▲ | 1.44▲ | 0.58▲ |
| MA50 | 1.41▲ | 1.46▲ | 1.45▲ | 0.86▲ | 0.56▲ |
| MA100 | 1.47▲ | 1.44▲ | 1.43▲ | 0.58▲ | 1.58▼ |
| MA200 | 1.43▲ | 1.40▲ | 1.01▲ | 0.53▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 0.016▲ | 0.011▲ | -0.053▼ | 0.157▲ |
| RSI | 62.692▲ | 60.399▲ | 58.059▲ | 60.187▲ | 72.032▲ |
| STOCH | 97.222▲ | 66.601 | 51.313 | 21.269 | 28.606 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -63.793 | -65.589 |
| CCI | 139.642▲ | 194.790▲ | 143.158▲ | -53.436 | 72.871 |
|
Thursday, April 30, 2026 02:55 PM
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 HOUSTON, April 30, 2026 (GLOBE NEWSWIRE)-- FibroBiologics, Inc. (Nasdaq: FBLG) ...
|
|
Thursday, April 30, 2026 05:45 AM
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
|
|
Friday, April 24, 2026 04:55 PM
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 1.29 | 1.51 | 1.25 | 1.46 | 288,111 |
| 30/04/26 | 1.32 | 1.37 | 1.30 | 1.32 | 26,921 |
| 29/04/26 | 1.38 | 1.43 | 1.27 | 1.31 | 129,697 |
| 28/04/26 | 1.44 | 1.48 | 1.33 | 1.36 | 131,133 |
| 27/04/26 | 1.43 | 1.4949 | 1.40 | 1.43 | 50,394 |
| 24/04/26 | 1.53 | 1.5348 | 1.40 | 1.42 | 114,049 |
| 23/04/26 | 1.50 | 1.5395 | 1.45 | 1.51 | 77,610 |
| 22/04/26 | 1.50 | 1.57 | 1.50 | 1.56 | 88,120 |
| 21/04/26 | 1.53 | 1.59 | 1.45 | 1.52 | 174,671 |
| 20/04/26 | 1.55 | 1.61 | 1.41 | 1.53 | 205,529 |
|
|
||||
|
|
||||
|
|